Deferred Income Tax Expense (Benefit) in USD of CHEMED CORP from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
CHEMED CORP quarterly/annual Deferred Income Tax Expense (Benefit) history and change rate from Q1 2010 to Q1 2025.
  • CHEMED CORP Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2025 was -$14.2M, a 161% decline year-over-year.
  • CHEMED CORP annual Deferred Income Tax Expense (Benefit) for 2024 was -$4.14M, a 48.4% increase from 2023.
  • CHEMED CORP annual Deferred Income Tax Expense (Benefit) for 2023 was -$8.03M, a 154% decline from 2022.
  • CHEMED CORP annual Deferred Income Tax Expense (Benefit) for 2022 was $14.8M, a 518% increase from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

CHEMED CORP Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$14.2M -$8.75M -161% 01 Jan 2025 31 Mar 2025 10-Q 28 Apr 2025
Q1 2024 -$5.42M -$2.23M -69.7% 01 Jan 2024 31 Mar 2024 10-Q 28 Apr 2025
Q1 2023 -$3.2M +$852K +21.1% 01 Jan 2023 31 Mar 2023 10-Q 29 Apr 2024
Q1 2022 -$4.05M -$3.12M -335% 01 Jan 2022 31 Mar 2022 10-Q 28 Apr 2023
Q1 2021 -$930K -$3.22M -141% 01 Jan 2021 31 Mar 2021 10-Q 29 Apr 2022
Q1 2020 $2.29M +$5.78M 01 Jan 2020 31 Mar 2020 10-Q 30 Apr 2021
Q1 2019 -$3.49M -$682K -24.3% 01 Jan 2019 31 Mar 2019 10-Q 01 May 2020
Q1 2018 -$2.81M -$392K -16.2% 01 Jan 2018 31 Mar 2018 10-Q 02 May 2019
Q1 2017 -$2.42M +$1.79M +42.5% 01 Jan 2017 31 Mar 2017 10-Q 27 Apr 2018
Q1 2016 -$4.2M -$1.47M -53.7% 01 Jan 2016 31 Mar 2016 10-Q 28 Apr 2017
Q1 2015 -$2.73M -$9.58M -140% 01 Jan 2015 31 Mar 2015 10-Q 02 May 2016
Q1 2014 $6.84M +$7.52M 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015
Q1 2013 -$681K +$2.72M +80% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014
Q1 2012 -$3.4M -$4.21M -517% 01 Jan 2012 31 Mar 2012 10-Q 26 Apr 2013
Q1 2011 $814K +$3.1M 01 Jan 2011 31 Mar 2011 10-Q 30 Apr 2012
Q1 2010 -$2.28M 01 Jan 2010 31 Mar 2010 10-Q 29 Apr 2011

CHEMED CORP Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.14M +$3.89M +48.4% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 -$8.03M -$22.9M -154% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 $14.8M +$12.4M +518% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 $2.4M +$967K +67.5% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024
2020 $1.43M +$4.2M 01 Jan 2020 31 Dec 2020 10-K 27 Feb 2023
2019 -$2.77M -$7.96M -153% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 $5.19M +$2.78M +115% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 $2.41M +$9.11M 01 Jan 2017 31 Dec 2017 10-K 26 Feb 2020
2016 -$6.71M -$13M -206% 01 Jan 2016 31 Dec 2016 10-K 27 Feb 2019
2015 $6.33M -$653K -9.36% 01 Jan 2015 31 Dec 2015 10-K 26 Feb 2018
2014 $6.98M +$14M 01 Jan 2014 31 Dec 2014 10-K 27 Feb 2017
2013 -$6.99M -$3.84M -122% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016
2012 -$3.15M -$10.4M -144% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $7.24M +$9.65M 01 Jan 2011 31 Dec 2011 10-K 27 Feb 2014
2010 -$2.41M 01 Jan 2010 31 Dec 2010 10-K 27 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.